UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
Current
Report Pursuant
to
Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of
Report (Date of earliest event reported)
September 18, 2008
PRESSURE
BIOSCIENCES, INC.
(Exact
Name of Registrant as Specified in its Charter)
(State
or
Other Jurisdiction of Incorporation)
|
0-21615
|
|
04-2652826
|
|
(Commission
File Number)
|
|
(IRS
Employer Identification No.)
|
|
14
Norfolk Avenue, South Easton, MA
|
|
02375
|
|
(Address
of Principal Executive Offices)
|
|
(Zip
Code)
|
(Registrant’s
Telephone Number, Including Area Code)
(Former
Name or Former Address, if Changed Since Last Report)
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see
General
Instruction A.2. below):
[
]
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
[
]
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[
]
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
[
] Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item
8.01 Other
Information
On
September 18, 2008, Pressure BioSciences, Inc. (the “Company”) submitted a
purchase order to Source Scientific, LLC, the manufacturer of the Company’s PCT
Barocycler instrumentation, for 50 Barocycler NEP2320 units. Pursuant to the
terms of the purchase order, the Company placed a deposit with Source
Scientific, LLC, of approximately $100,000, representing approximately 25%
of
the expected total value of the order. The Company will place an additional
deposit of approximately $100,000 with Source Scientific, LLC, upon their
commencement of the manufacture of the units, expected to be early in the fourth
quarter of 2008. The purchase price for the 50 Barocycler NEP2320 units is
based
upon a fixed bill of materials. The Company expects that the NEP2320 units
will
be completed and ready for sale to its customers during the first quarter of
2009.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant
has
duly caused this Report to be signed on its behalf by the undersigned, thereunto
duly authorized.
|
Dated:
September 19, 2008
|
PRESSURE
BIOSCIENCES, INC.
|
| |
|
| |
|
| |
|
| |
By:
/s/ Edward H. Myles
|
| |
Edward
H. Myles, Senior Vice President of Finance
|
| |
and
Chief Financial Officer
|